SEC Form 4 · accession 0000899243-15-007544
KalVista Pharmaceuticals, Inc. · KALV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John McKune
Officer — See Remarks
Period of report
Nov 2, 2015
Accepted (ET)
Nov 4, 2015 · 11:46 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001348911
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $4.01 | Nov 2, 2015 | A | 50,000 | A | — | Nov 2, 2025 | Common Stock | 50,000 | 50,000 | D |
Explanation of responses
- F1The option shall vest with respect to one-quarter of the underlying shares upon the first anniversary of the vesting commencement date of August 5, 2015, and then with respect to the remaining shares monthly thereafter over the next three years.
Remarks
Corporate Controller & Principal Accounting Officer